Posts Tagged: vaccines


A Third Option: Limited IP Waiver Could Solve Our Pandemic Vaccine Problems

In the early days of the vaccination efforts, Americans were anxiously online trying to register for a COVID-19 vaccination appointment. Reports of success at 1:30 am and 2:30 am …

Emerging Anti-IP Policies the Focus of Heritage Foundation Event

At today’s Heritage Foundation event in Washington, D.C., titled Restoring American Leadership in Patent Law and Innovation Policy, former U.S. Patent and Trademark Office …
By Gene Quinn
14 days ago 10

TRIPS IP Waiver Could Establish Dangerous Precedent for Climate Change and Other Biotech Sectors

While the discussions around waiving intellectual property (IP) rights set forth in the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) are currently (and somewhat amorphously) …
By Melissa Brand
2 months ago 3

Waiving IP Rights During Times of COVID: A ‘False Good Idea’

Over the course of four months, close to 850 million doses of COVID-19 vaccines have been administered in over 100 countries. To the extent the unprecedented pace of research, …
By Hans Sauer
4 months ago 37

Countries Like the Philippines are Unable to Utilize IP Flexibilities to Fight COVID-19

The Philippines has so far relied on donations and direct purchase to obtain vaccines to address the pandemic. As of March 2021, the Philippines received 2 million Sinovac doses …

The mRNA IP and Competitive Landscape Through One Year of the COVID-19 Pandemic – Part I

Shortly after we posted about Moderna, Inc.’s October 2020 pledge not to enforce its COVID-19-related patents during the pandemic, the United States Food & Drug Administration (FDA) …

Why Innovation Would Survive a COVID-19 TRIPS Waiver

Intellectual property protection has played an important role in this pandemic. As some have pointed out, without legal protection for innovative ideas, there may not have been …
By Rachel Thrasher
4 months ago 0

Gutting Patents Won’t Speed the COVID-19 Vaccine Rollout

India and South Africa recently urged the World Trade Organization to suspend intellectual property protections for COVID-19 vaccines and treatments. The claim is that this would allow …
By Peter J. Pitts
6 months ago 4

Pfizer Rejects Accusations it Infringed COVID-19 Vaccine Assay Technology

Pfizer and BioNTech have hit back at Allele Biotechnology and Pharmaceuticals, Inc.’s October 2020 complaint accusing the COVID-19 vaccine manufacturers of infringing Allele’s U.S. patent …
By La'Cee Conley
6 months ago 2

The Biden Administration is at an Innovation Crossroad

The new Presidential Administration has hardly settled in before being confronted with a stark choice: will they continue policies that foster public/private sector R&D partnerships …
By Joseph Allen
6 months ago 2

Should the Biden Administration Look to Pharma for New USPTO Director?

The United States is not even two weeks into the administration of President Joe Biden and it’s likely that the administration’s selection for Director of …
By Steve Brachmann
6 months ago 7

Free Advice to the New Administration: Weakening Bayh-Dole Courts Disaster

Almost two weeks after election day, it's still not entirely certain who won (has there ever been a crazier year than 2020), but it appears increasingly likely that …
By Joseph Allen
9 months ago 1

Tillis and Blackburn Introduce Anti-Hacking Bill Aimed at Protecting COVID-19 Vaccine Research

The Defend COVID Research from Hackers Act was introduced on Tuesday by Senators Thom Tillis (R-NC) and Marsha Blackburn (R-TN) with the goal of authorizing the President …
By IPWatchdog
10 months ago 2

Regeneron, Pfizer and BioNTech Accused of Infringing Allele Patent in Connection with COVID-19 Technologies

Allele Biotechnology and Pharmaceuticals, Inc. (Allele) has accused Regeneron Pharmaceuticals, Inc. (Regeneron); Pfizer, Inc. (Pfizer); and BioNTech SE and BioNTech US, Inc. (collectively BioNTech) for allegedly infringing …
By Rebecca Tapscott
10 months ago 3

Panelists Urge Americans to Trust IP, Trust Vaccines, Listen to Science in COVID-19 Debate

IPWatchdog’s most recent webinar focused on the role of IP in the development of the most promising vaccines to combat COVID-19 and included speakers from the …
By Eileen McDermott
10 months ago 2